FDA BRIEFING DOCUMENT NDA[removed]DAPAGLIFLOZIN TABLETS, 5 AND 10 MG

First Page		Document Content
Diabetes Health Organochlorides Bristol-Myers Squibb Thiazolidinediones Dapagliflozin Metformin Anti-diabetic medication SLC5A2 Medicine Chemistry Anti-diabetic drugs		FDA BRIEFING DOCUMENT NDA[removed]DAPAGLIFLOZIN TABLETS, 5 AND 10 MG Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 3,89 MB Share Document on Facebook

	DOCX Document DocID: 17hG7 - View Document
	CLINICAL SGLT2 inhibition with dapagliflozin Gary Kilov Stephen Leow DocID: 1465v - View Document
	Microsoft Word - final_150414_e.docx DocID: 13VvB - View Document
	License Agreement of SGLT2 Inhibitor “CSG452” in Japan DocID: ZwJo - View Document
	Forxiga_12_04_PR_antidiabetic DocID: RJQ3 - View Document